CA9 and cancer: A further investigation has shown that increased CA-related enzymatic function is measurable in plasmatic exosomes from cancer patients [51], suggesting that CA-IX expression and activity in plasmatic exosomes preparation may represent a new valuable cancer biomarker in the near future [20,52].